613
Views
0
CrossRef citations to date
0
Altmetric
Articles

A Content Analysis of Self-Reported Financial Relationships in Biomedical Research

ORCID Icon, ORCID Icon, , ORCID Icon, ORCID Icon & ORCID Icon

References

  • Ahmer, S., P. Arya, D. Anderson, and R. Faruqui. 2005. Conflict of interest in psychiatry. Psychiatric Bulletin 29 (8):302–4. doi: 10.1192/pb.29.8.302.
  • Ahn, R., A. Woodbridge, A. Abraham, S. Saba, D. Korenstein, E. Madden, W. J. Boscardin, and S. Keyhani. 2017. Financial ties of principal investigators and randomized controlled trial outcomes: cross sectional study. BMJ (Clinical Research ed.) 356:i6770. doi: 10.1136/bmj.i6770.
  • Als-Nielsen, B., W. Chen, C. Gluud, and L. L. Kjaergard. 2003. Association of funding and conclusions in randomized drug trials A reflection of treatment effect or adverse events? JAMA 290 (7):921–8. doi: 10.1001/jama.290.7.921.
  • Bellomo, T. R., C. Hwang, and M. A. Corriere. 2019. Scope and prevalence of conflicts of interest among highly cited peripheral artery disease research studies. Journal of Vascular Surgery 69 (1): e7–e8. doi: 10.1016/j.jvs.2018.10.018.
  • Bighelli, I., C. Leucht, M. Huhn, C. Reitmeir, F. Schwermann, S. Wallis, J. M. Davis, and S. Leucht. 2020. Are randomized controlled trials on pharmacotherapy and psychotherapy for positive symptoms of schizophrenia comparable? A systematic review of patient and study characteristics. Schizophrenia Bulletin 46 (3):496–504. doi: 10.1093/schbul/sbz090.
  • Bond, K., C. Spooner, L. Tjosvold, C. Lemière, and B. H. Rowe. 2012. The nature and influence of pharmaceutical industry involvement in asthma trials. Canadian Respiratory Journal 19 (4):267–71. doi: 10.1155/2012/890457.
  • Brems, J. H., and M. S. McCoy. 2019. A content analysis of patient advocacy organization policies addressing institutional conflicts of interest. AJOB Empirical Bioethics 10 (4):215–21. doi: 10.1080/23294515.2019.1670278.
  • Cherla, D. V., C. P. Viso, J. L. Holihan, K. Bernardi, M. L. Moses, K. M. Mueck, O. A. Olavarria, J. R. Flores-Gonzalez, C. J. Balentine, T. C. Ko, et al. 2019. The effect of financial conflict of interest, disclosure status, and relevance on medical research from the United States. Journal of General Internal Medicine 34 (3):429–34. doi: 10.1007/s11606-018-4784-0.
  • Collins, M. 2017. PubMed updates March 2017. NLM Technical Bulletin 415:e2.
  • Drazen, J. M., M. B. Van der Weyden, P. Sahni, J. Rosenberg, A. Marusic, C. Laine, S. Kotzin, R. Horton, P. C. Hébert, C. Haug, et al. 2009. Uniform format for disclosure of competing interests in ICMJE journals. The New England Journal of Medicine 361 (19):1896–7. doi: 10.1056/NEJMe0909052.
  • Etter, J.-F., M. Burri, and J. Stapleton. 2007. The impact of pharmaceutical company funding on results of randomized trials of nicotine replacement therapy for smoking cessation: A meta-analysis. Addiction (Abingdon, England) 102 (5):815–22. doi: 10.1111/j.1360-0443.2007.01822.x.
  • Falagas, M. E., V. D. Kouranos, R. Arencibia-Jorge, and D. E. Karageorgopoulos. 2008. Comparison of SCImago journal rank indicator with journal impact factor. FASEB Journal: Official Publication of the Federation of American Societies for Experimental Biology 22 (8):2623–8. doi: 10.1096/fj.08-107938.
  • Flacco, M. E., L. Manzoli, S. Boccia, L. Capasso, K. Aleksovska, A. Rosso, G. Scaioli, C. De Vito, R. Siliquini, P. Villari, et al. 2015. Head-to-head randomized trials are mostly industry sponsored and almost always favor the industry sponsor. Journal of Clinical Epidemiology 68 (7):811–20. doi: 10.1016/j.jclinepi.2014.12.016.
  • Grundy, Q., A. G. Dunn, F. T. Bourgeois, E. Coiera, and L. Bero. 2018. Prevalence of disclosed conflicts of interest in biomedical research and associations with journal impact factors and altmetric scores. JAMA 319 (4):408–9. doi: 10.1001/jama.2017.20738.
  • Hajian-Tilaki, K. 2011. Sample size estimation in epidemiologic studies. Caspian Journal of Internal Medicine 2 (4):289–98.
  • Hampson, L., S. Joffe, R. Fowler, J. Verter, and E. Emanuel. 2007. Frequency, type, and monetary value of financial conflicts of interest in cancer clinical research. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 25 (24):3609–14. doi: 10.1200/JCO.2006.09.3633.
  • Jagsi, R., N. Sheets, A. Jankovic, A. R. Motomura, S. Amarnath, and P. A. Ubel. 2009. Frequency, nature, effects, and correlates of conflicts of interest in published clinical cancer research. Cancer 115 (12):2783–91. doi: 10.1002/cncr.24315.
  • Krippendorff, K. 2018. Content analysis: An introduction to its methodology. Thousand Oaks: SAGE Publications.
  • Lent, M. v., J. Overbeke, and H. J. Out. 2014. Role of editorial and peer review processes in publication bias: Analysis of drug trials submitted to eight medical journals. PloS One 9 (8):e104846. doi: 10.1371/journal.pone.0104846.
  • Lerner, T. G., M. d C. Miranda, A. T. Lera, A. Ueda, B. Briones, A. Del Giglio, and R. Riechelmann. 2012. The prevalence and influence of self-reported conflicts of interest by editorial authors of phase III cancer trials. Contemporary Clinical Trials 33 (5):1019–22. doi: 10.1016/j.cct.2012.05.011.
  • Lopez, J., L. Musavi, A. Quan, N. Calotta, I. Juan, A. Park, A. P. Tufaro, J. W. May, and A. H. Dorafshar. 2017. Trends, frequency, and nature of surgeon-reported conflicts of interest in plastic surgery. Plastic and Reconstructive Surgery 140 (4):852–61. doi: 10.1097/PRS.0000000000003683.
  • Lopez, J., S. Lopez, J. Means, R. Mohan, A. Soni, J. Milton, A. P. Tufaro, J. W. May, and A. Dorafshar. 2015. Financial conflicts of interest: An association between funding and findings in plastic surgery. Plastic and Reconstructive Surgery 136 (5):690e–7e. doi: 10.1097/PRS.0000000000001718.
  • Lundh, A., J. Lexchin, B. Mintzes, J. B. Schroll, and L. Bero. 2017. Industry sponsorship and research outcome. The Cochrane Database of Systematic Reviews 2 (2):MR000033. doi: 10.1002/14651858.MR000033.pub3.
  • Perlis, R. H., C. S. Perlis, Y. Wu, C. Hwang, M. Joseph, and A. A. Nierenberg. 2005. Industry sponsorship and financial conflict of interest in the reporting of clinical trials in psychiatry. The American Journal of Psychiatry 162 (10):1957–60. doi: 10.1176/appi.ajp.162.10.1957.
  • Raman, S., F. Y. Moraes, L. C. Mendez, N. K. Taunk, J. H. Suh, L. Souhami, B. Slotman, P. Kongkham, D. E. Spratt, A. Berlin, et al. 2018. The relationship of study and authorship characteristics on trial sponsorship and self-reported conflicts of interest among neuro-oncology clinical trials. Journal of Neuro-Oncology 139 (1):195–203. doi: 10.1007/s11060-018-2860-2.
  • Rasmussen, K., J. Schroll, P. C. Gøtzsche, and A. Lundh. 2015. Under-reporting of conflicts of interest among trialists: A cross-sectional study. Journal of the Royal Society of Medicine 108 (3):101–7. doi: 10.1177/0141076814557878.
  • Rattinger, G., and L. Bero. 2009. Factors associated with results and conclusions of trials of thiazolidinediones. PloS One 4 (6):e5826. doi: 10.1371/journal.pone.0005826.
  • Riaz, H., M. S. Khan, I. B. Riaz, S. Raza, A. R. Khan, and R. A. Krasuski. 2016. Conflicts of interest and outcomes of cardiovascular trials. The American Journal of Cardiology 117 (5):858–60. doi: 10.1016/j.amjcard.2015.12.011.
  • Scott, G. S., Z. P. Majdik, and D. Clark. 2020. Methods for extracting relational data from unstructured texts prior to network visualization in humanities research. Journal of Open Humanities Data 6 (1):8. doi: 10.5334/johd.21.
  • Scott, G. S., Z. P. Majdik, D. Clark, M. M. Kessler, and T. B. Hooker. 2020. Relationships among commercial practices and author conflicts of interest in biomedical publishing. PloS One 15 (7):e0236166. doi: 10.1371/journal.pone.0236166.
  • Scott, G. S., Z. P. Majdik, J. B. Barbour, and J. F. Rousseau. 2022. Associations between aggregate NLP-extracted conflicts of interest and adverse events by drug product. Studies in Health Technology and Informatics 290:405–9. doi: 10.3233/SHTI220106.
  • Waqas, A., A. A. Baig, M. A. Khalid, K. K. Aedma, and S. Naveed. 2019. Conflicts of interest and outcomes of clinical trials of antidepressants: An 18-year retrospective study. Journal of Psychiatric Research 116:83–7. doi: 10.1016/j.jpsychires.2019.05.029.
  • Wickham, H. n.d. Data manipulation with Plyr, 81.